Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
53.2M
-
Shares change
-
+3.49M
-
Total reported value, excl. options
-
$630M
-
Value change
-
+$46.1M
-
Number of buys
-
53
-
Number of sells
-
-29
-
Price
-
$11.84
Significant Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) as of Q1 2023
93 filings reported holding TERN - Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q1 2023.
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.2M shares
of 87.4M outstanding shares and own 60.93% of the company stock.
Largest 10 shareholders include FMR LLC (7.64M shares), ORBIMED ADVISORS LLC (7.62M shares), Vivo Capital, LLC (6.66M shares), VR Adviser, LLC (3.62M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.45M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.47M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.06M shares), Fairmount Funds Management LLC (2.04M shares), BRAIDWELL LP (2M shares), and FRANKLIN RESOURCES INC (1.46M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.